Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
featured
Published in Eye Care

Journal Scan / Review · August 21, 2018

CRISPR-Cas9 Genome Engineering: Treating Inherited Retinal Degeneration

Progress in Retinal and Eye Research

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Joseph Sassani MD

Myron Yanoff MD

Progress in Retinal and Eye Research
CRISPR-Cas9 Genome Engineering: Treating Inherited Retinal Degeneration
Prog Retin Eye Res 2018 Jul 01;65(xx)28-49, ER Burnight, JC Giacalone, JA Cooke, JR Thompson, LR Bohrer, KR Chirco, AV Drack, JH Fingert, KS Worthington, LA Wiley, RF Mullins, EM Stone, BA Tucker

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated